Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs in the United States. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial...
3 insider purchases on record · latest filing 2024-08-19.
Insiders have also filed 1 sale transaction at HOTH.